The Covid-19 vaccination coverage in the country has crossed 62 crore doses, which is a good sign indeed.
Covid-19 could be entering a stage of endemicity in India, with low to moderate levels of transmission, according to World Health Organization Chief Scientist Dr Soumya Swaminathan.
India's drug regulator approved Zydus Cadila's ZyCoV-D Covid Vaccine for emergency use in children above 12 years of age.
"Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2/3 trials."
Coronavirus cases continue to rise across the United States, led by the fast-spreading and highly infectious Delta Variant.
In clinical studies, the US pharmaceutical giant says that its vaccine was 85 percent successful in avoiding the medical condition.